Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Researchers say semaglutide may help reverse MASH, a progressive liver condition affecting millions of Americans.

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

FAT jabs can treat a liver disease affecting one in five people, a trial found. Semaglutide cut inflammation in two thirds of ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ — 63%, compared with 34% of those taking a placebo, researchers reported ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

There could be a new use for semaglutide, the main ingredient of weight loss and diabetes drugs Wegovy and Ozempic. Dr. Jon ...